These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 20143956)
1. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury. Brunswig-Spickenheier B; Boche J; Westenfelder C; Peimann F; Gruber AD; Jaquet K; Krause K; Zustin J; Zander AR; Lange C Stem Cells Dev; 2010 May; 19(5):719-29. PubMed ID: 20143956 [TBL] [Abstract][Full Text] [Related]
2. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice. Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451 [TBL] [Abstract][Full Text] [Related]
3. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878 [TBL] [Abstract][Full Text] [Related]
5. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury. Si X; Liu X; Li J; Wu X Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423 [TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury. Rodrigues CE; Capcha JM; de Bragança AC; Sanches TR; Gouveia PQ; de Oliveira PA; Malheiros DM; Volpini RA; Santinho MA; Santana BA; Calado RD; Noronha IL; Andrade L Stem Cell Res Ther; 2017 Jan; 8(1):19. PubMed ID: 28129785 [TBL] [Abstract][Full Text] [Related]
9. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing. Liu X; Cai J; Jiao X; Yu X; Ding X Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):338-348. PubMed ID: 28338909 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives. Hu H; Zou C Curr Stem Cell Res Ther; 2017; 12(3):183-187. PubMed ID: 27781940 [TBL] [Abstract][Full Text] [Related]
12. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model. Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377 [TBL] [Abstract][Full Text] [Related]
13. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785 [TBL] [Abstract][Full Text] [Related]
14. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465 [TBL] [Abstract][Full Text] [Related]
15. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Luo CJ; Zhang FJ; Zhang L; Geng YQ; Li QG; Hong Q; Fu B; Zhu F; Cui SY; Feng Z; Sun XF; Chen XM Shock; 2014 Feb; 41(2):123-9. PubMed ID: 24169208 [TBL] [Abstract][Full Text] [Related]